| Literature DB >> 24391986 |
Hongxiao Han1, Jinbiao Peng2, Yanhui Han3, Min Zhang3, Yang Hong3, Zhiqiang Fu3, Jianmei Yang3, Jianping Tao4, Jiaojiao Lin5.
Abstract
The reed vole Microtus fortis is the only mammal known in China in which the growth, development and maturation of schistosomes (Schistosoma japonicum) is prevented. It might be that the anti-schistosomiasis mechanisms of M. fortis associate with microRNA-mediated gene expression, given that the latter has been found to be involved in gene regulation in eukaryotes. In the present study, the difference between pathological changes in tissues of M. fortis and of mice (Mus musculus) post-schistosome infection were observed by using hematoxylin-eosin staining. In addition, microarray technique was applied to identify differentially expressed miRNAs in the same tissues before and post-infection to analyze the potential roles of miRNAs in schistosome infection in these two different types of host. Histological analyses showed that S. japonicum infection in M. fortis resulted in a more intensive inflammatory response and pathological change than in mice. The microarray analysis revealed that 162 miRNAs were expressed in both species, with 12 in liver, 32 in spleen and 34 in lung being differentially expressed in M. fortis. The functions of the differentially expressed miRNAs were mainly revolved in nutrient metabolism, immune regulation, etc. Further analysis revealed that important signaling pathways were triggered after infection by S. japonicum in M. fortis but not in the mice. These results provide new insights into the general mechanisms of regulation in the non-permissive schistosome host M. fortis that exploits potential miRNA regulatory networks. Such information will help improve current understanding of schistosome development and host-parasite interactions.Entities:
Mesh:
Substances:
Year: 2013 PMID: 24391986 PMCID: PMC3877346 DOI: 10.1371/journal.pone.0085080
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Figure 1Histopathology of different tissue sections prepared from M. fortis by HE staining.
(A-F) tissues prepared from M.fortis (×400),(A) uninfected liver, (B) infected liver, (C) uninfected lung, (D) infected lung, (E) uninfected spleen, (F) infected spleen, macrophages were observed. Bar=20μm.
Figure 2Expression profiling of miRNAs in different tissues of M. fortis and mice following S. japonicum infection.
A:Comparison of observed miRNA in liver, spleen and lung of M. fortis and mice; B-D: miRNA expression profile in different tissue of M.fortis and mice following S.japonicum infection. The left and right panel shows a heat-map of selected miRNAs that showed changes in expression in different tissue in M. fortis and mice following S. japonicum infection. B: differentially expressed miRNA in liver, C: differentially expressed miRNA in spleen, D: differentially expressed miRNA in lung. Clustering of the microarray showing the stastically significant(*p<0.05) miRNAs in different tissues of M. fortis compared with mice. Three replicates from each tissue cluster together. Both up-regulated (the red color ) and down-regulated (the green color) miRNAs from the mean were identified. Then Columns and rows represent samples and particular miRNAs.
Examples of differentially expressed miRNAs in different tissues in M.fortis compared with mice infected with S japonicum.
| Tissue | miRNA |
| Mice | Tissue | miRNA |
| Mice | Tissue | miRNA |
| Mice | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fold change | Fold change | Fold change | ||||||||||||
| (infected/uninfected) | (infected/uninfected) | (infected/uninfected) | ||||||||||||
| rno-miR-223 | 18.38 | mmu-miR-691 | 20.68 | 5.21 | rno-miR-223 | 9.25 | 0.05 | |||||||
| mmu-miR-223 | 8.34 | mmu-miR-328* | 3.51 | 4.5 | mmu-miR-1195 | 8.22 | 0.74 | |||||||
| rno-miR-365* | 4.76 | mmu-miR-467a* | 3.14 | 1.33 | rno-miR-328a* | 8 | 0.16 | |||||||
| mmu-miR-122 | 3.92 | 1.12 | rno-miR-665 | 3.07 | 7.36 | mmu-miR-466f | 7.52 | 1.07 | ||||||
| mmu-miR-146a | 3.76 | 0.97 | mmu-miR-467d* | 3.07 | 1.17 | mmu-miR-466j | 7.52 | 1.01 | ||||||
| mmu-miR-705 | 2.39 | 0.64 | mmu-miR-467b* | 2.85 | 1.19 | rno-miR-494 | 6.54 | 0.68 | ||||||
| mmu-miR-872 | 2.19 | rno-miR-223 | 2.73 | 0.8 | mmu-miR-223 | 4.96 | 0.14 | |||||||
| mmu-miR-467b* | 2 | 1.16 | mmu-miR-494 | 2.68 | 5.43 | mmu-miR-705 | 3.16 | 0.24 | ||||||
| mmu-miR-328* | 0.5 | 3.27 | mmu-miR-574-3p | 2.43 | 1.69 | mmu-miR-483 | 2.71 | 1 | ||||||
| Liver | mmu-miR-27a | 0.49 | 2.03 | mmu-miR-2137 | 2.28 | 1.04 | mmu-miR-762 | 2.69 | 0.23 | |||||
| mmu-miR-30e | 0.47 | 2.77 | mmu-miR-466g | 2.17 | 0.97 | mmu-miR-1895 | 2.6 | 0.81 | ||||||
| mmu-miR-322 | 0.38 | mmu-miR-669e* | 2.14 | 1.25 | mmu-miR-574-5p | 2.41 | 0.97 | |||||||
| mmu-miR-3107 | 0.35 | 0.65 | Spleen | mmu-miR-669c* | 2.11 | 1.25 | lung | mmu-miR-1224 | 2.33 | 0.22 | ||||
| mmu-miR-1195 | 0.32 | 3.78 | mmu-miR-466q | 2.1 | 1.22 | mmu-miR-497 | 0.49 | |||||||
| mmu-miR-451 | 0.3 | 1.42 | mmu-miR-466m-3p | 2.08 | 1.79 | mmu-miR-150 | 0.48 | 0.24 | ||||||
| mmu-miR-193 | 0.28 | 0.45 | mmu-miR-27a | 0.49 | 1.06 | mmu-miR-143 | 0.47 | 2.93 | ||||||
| rno-miR-196c* | 0.19 | 4.44 | mmu-miR-145 | 0.47 | 1.15 | mmu-miR-181a | 0.45 | 4.23 | ||||||
| mmu-miR-181c | 0.17 | mmu-miR-15a | 0.44 | 0.72 | mmu-miR-30e | 0.43 | 15.24 | |||||||
| mmu-miR-107 | 0.44 | 0.81 | mmu-miR-100 | 0.42 | 8.46 | |||||||||
| mmu-miR-125b-5p | 0.44 | 0.68 | rno-miR-143 | 0.41 | 3.01 | |||||||||
| mmu-miR-99b | 0.42 | 0.63 | mmu-miR-181b | 0.41 | 7.78 | |||||||||
| mmu-miR-143 | 0.41 | 0.66 | mmu-miR-99a | 0.4 | 13.64 | |||||||||
| mmu-miR-125a-5p | 0.38 | 0.9 | mmu-miR-375 | 0.35 | ||||||||||
| mmu-miR-151-5p | 0.38 | 0.51 | mmu-miR-200a | 0.33 | 71.01 | |||||||||
| mmu-miR-126-3p | 0.33 | 0.67 | mmu-miR-10a | 0.33 | 6.02 | |||||||||
| mmu-miR-99a | 0.33 | mmu-miR-29c | 0.31 | 0.44 | ||||||||||
| mmu-miR-10a | 0.32 | mmu-miR-34c | 0.31 | |||||||||||
| mmu-miR-100 | 0.29 | mmu-miR-34b-3p | 0.25 | |||||||||||
| mmu-miR-10b | 0.29 | mmu-miR-429 | 0.23 | |||||||||||
| mmu-miR-335-5p | 0.25 | mmu-miR-322 | 0.23 | 11.24 | ||||||||||
A full list of differentially expressed miRNAs in different tissues in M.fortis compared with mice infected with S japonicum is shown in Table S2
Main functions of the differentially expressed miRNAs in different tissues in M.fortis infected with S. japonicum.
| Tissue | miRNA | Function |
|---|---|---|
| Up-regulated | ||
| mmu-miR-122 | regulation of cholesterol metabolism;a regulator of fatty-acid metabolism | |
| mmu-miR-146a | regulation of Monocyte Functional;regulation of inflammation and function in the innate immune system | |
| mmu-miR-705 | regulation lipid metabolism and inflammation | |
| Liver | mmu-miR-223 | promoting granulocytic differentiation and suppression of erythrocytic differentiation |
| Down-regulated | ||
| mmu-miR-27a | negative regulator of adipocyte differentiation | |
| mmu-miR-451 | erythroiddifferentiation;regulates the drug-transporter protein P-glycoprotein | |
| mmu-miR-193 | regulation of adipogenesis | |
| Up-regulated | ||
| mmu-miR-494 | targeting proapoptotic and antiapoptotic proteins | |
| Down-regulated | ||
| Spleen | mmu-miR-15a | regulation of lymphoid development |
| mmu-miR-107 | regulation of macrophage adhesion; regulator of insulin sensitivity | |
| mmu-miR-125a-5p | regulation of the inflammatory response and lipid uptake | |
| Up-regulated | ||
| mmu-miR-223 | regulated in immune response;promoting granulocytic differentiation and suppression of erythrocytic differentiation | |
| mmu-miR-1224 | regulation of tumour necrosis factor | |
| mmu-miR-705 | regulation lipid metabolism and inflammation | |
| Down-regulated | ||
| Lung | mmu-miR-150 | differentiating stem cells towards megakaryocytes and control B and T cell differentiation |
| mmu-miR-143 | regulation of adipocyte Differentiation | |
| mmu-miR-30e | corresponding gain in Bcl-2 expression and decreases in pro-apoptosis genes | |
| mmu-miR-200a | regulated in immune response | |
| mmu-miR-375 | regulate glucagon levels and gluconeogenesis | |
| mmu-miR-34c | part of the p53 tumor suppressor network | |
| mmu-miR-34b-3p | part of the p53 tumor suppressor network | |
The full list of the functions of the differentially expressed miRNAs in different tissues infected with S. japonicum in M.fortis with the related reference is in Table S3.
Figure 3The statistics of predicted target genes for differentially expressed miRNAs in M. fortis compared with mice following S. japonicum infection.
Up-regulated miRNAs in M. fortis were listed on the upper chart (A) and down-regulated miRNAs were in the lower chart (B). All the target genes show increased number. The vertical axis is the differentially expressed miRNAs and the horizontal axis is the target gene number.
Figure 4Pie charts showing the distribution of GOs for predicted target genes of differentially expressed miRNAs in M. fortis compared with mice following S. japonicum infection.
A represents the category of the GOs for predicted target genes of miRNAs up-regulated in liver, spleen and lung of M. fortis; B represents the category of the GOs for predicted target genes of miRNAs down-regulated in liver, spleen and lung of M. fortis. A full list of GO analysis for predicted target genes of differentially expressed miRNAs in M. fortis compared with mice infected with S. japonicum is shown in Table S4.
KEGG pathway of the targets of the differentially expressed miRNAs in different tissue of M.fortis following S.japonicum infection.
| Tissue | miRNA | KEGG pathway | Putative Target | P value |
|---|---|---|---|---|
| Liver | Up-regulated miRNA | |||
| mmu-miR-705 | Neurotrophin signaling pathway | PDK1, MAPK1, YWHAZ, MAP3K3, GRB2, YWHAB, RHOA, RAF1, MAPKAPK2, TRAF6, FRS2, SHC2 | 2.39E-06 | |
| MAPK signaling pathway | GRB2, TAOK1, FGF11, RAF1, FGF10, ELK1, MAPKAPK2, STK3, FOS, MAPK1, MAP3K3, PAK2, PRKACA, NFATC4, TRAF6, RASA1 | 3.35E-05 | ||
| Chemokine signaling pathway | CCL1, MAPK1, ADCY1, GRB2, RHOA, RAF1, PRKACA, ADRBK1, GRK5, GNG4, SHC2 | 2.42E-03 | ||
| B cell receptor signaling pathway | FOS, MAPK1, GRB2, RAF1, NFATC4, CD79A | 1.82E-02 | ||
| Natural killer cell mediated cytotoxicity | MAPK1, TNFRSF10B, GRB2, RAF1, NFATC4, IFNGR2, SHC2 | 2.91E-02 | ||
| rno-miR-365* | Endocytosis | RAB11FIP4, GIT1, RAB5B, PDGFRA, LDLRAP1, AGAP3, EHD4 | 2.00E-02 | |
| Down-regulated miRNA | ||||
| mmu-miR-27a | MAPK signaling pathway | BRAF, MAPK14, GNA12, CACNG2, DUSP6 | 2.69E-04 | |
| mmu-miR-322 | Inositol phosphate metabolism | INPP5K, PIP5K1B, IPPK | 1.34E-02 | |
| Phosphatidylinositol signaling system | INPP5K, PIP5K1B, IPPK | 2.50E-02 | ||
| Up-regulated miRNA | ||||
| Spleen | mmu-miR-328* | MAPK signaling pathway | TAOK1, TGFBR1, RELA, CACNB1, MKNK2, TGFB3, MKNK1, CACNG2, CACNG1, AKT1, DUSP3, MAP3K3, DUSP14, RPS6KA2, PPP3CB, MAPK9, PDGFRB, CACNA1E, RASA1, MAP3K11 | 3.52E-08 |
| Cytokine-cytokine receptor interaction | IL9R, TNFRSF10B, OSMR, FLT4, TGFBR1, TGFB3, PDGFRB, EDAR, CD40, BMP7 | 1.79E-02 | ||
| Wnt signaling pathway | WNT1, PPARD, PPP2R5B, CCND2, PPP3CB, MAPK9, FZD6 | 3.48E-02 | ||
| Jak-STAT signaling pathway | AKT1, PTPN6, IL9R, CCND2, OSMR, BCL2L1, SPRY4 | 3.78E-02 | ||
| Down-regulated miRNA | ||||
| mmu-miR-125a-5p | MAPK signaling pathway | RPS6KA1, RAC3, MAP3K8, MAPKAPK2, TRAF6, MAP3K11 | 4.65E-02 | |
| mmu-miR-10a | Toll-like receptor signaling pathway | IFNAR2, IRF5, MAP2K6, TRAF3 | 5.48E-04 | |
| mmu-miR-10b | Toll-like receptor signaling pathway | IRF5, MAP2K6, TRAF3 | 7.71E-03 | |
| Up-regulated miRNA | ||||
| Lung | mmu-miR-466j | Calcium signaling pathway | EGFR, ADCY1, CACNA1E, CAMK2A | 4.40E-02 |
| mmu-miR-705 | Neurotrophin signaling pathway | PDK1, MAPK1, YWHAZ, MAP3K3, GRB2, YWHAB, RHOA, RAF1, MAPKAPK2, TRAF6, FRS2, SHC2 | 2.39E-06 | |
| MAPK signaling pathway | GRB2, TAOK1, FGF11, RAF1, FGF10, ELK1, MAPKAPK2, STK3, FOS, MAPK1, MAP3K3, PAK2, PRKACA, NFATC4, TRAF6, RASA1 | 3.35E-05 | ||
| Chemokine signaling pathway | CCL1, MAPK1, ADCY1, GRB2, RHOA, RAF1, PRKACA, ADRBK1, GRK5, GNG4, SHC2 | 2.42E-03 | ||
| B cell receptor signaling pathway | FOS, MAPK1, GRB2, RAF1, NFATC4, CD79A | 1.82E-02 | ||
| Natural killer cell mediated cytotoxicity | MAPK1, TNFRSF10B, GRB2, RAF1, NFATC4, IFNGR2, SHC2 | 2.91E-02 | ||
| Down-regulated miRNA | ||||
| mmu-miR-322 | Inositol phosphate metabolism | INPP5K, PIP5K1B, IPPK | 1.34E-02 | |
| Phosphatidylinositol signaling system | INPP5K, PIP5K1B, IPPK | 2.50E-02 | ||
| mmu-miR-34c | Insulin signaling pathway | RHOQ, MAPK9, MAPK8, PRKACB, LIPE, HRAS1 | 4.65E-03 | |
| Neurotrophin signaling pathway | PDK1, MAP3K3, MAPK9, MAPK8, HRAS1 | 1.97E-02 | ||
| Cytokine-cytokine receptor interaction | VEGFB, CSF1, TGFB3, PDGFRA, PDGFRB, IL13 | 4.43E-02 | ||
| mmu-miR-497 | Toll-like receptor signaling pathway | CD40, TAB1, TRAF6, IFNAR1, TRAF3 | 2.93E-02 | |
| MAPK signaling pathway | MAP3K3, TAOK1, PPP3CB, TGFB3, CACNA1E, TAB1, TRAF6, RASA1 | 3.63E-02 | ||
Figure 5miRNA-target-network.
Red cycle nodes represent mRNA and blue box nodes represent miRNA.
(A) Significant miRNAs differentially expressed in liver. The left subgraph shows up-regulated miRNA–mRNA network and the right is down-regulated.(B) Significant miRNAs differentially expressed in spleen or lung.The upper subgraph shows under-expression and the lower subgraph is the over-expression microRNA–mRNA network. Mmu-miR-125a-5p and mmu-miR-107 are under-expression miRNAs in spleen. Two miRNAs(mmu-miR-466f, mmu-miR-466j) are the highest degree in lung. Edges represent the inhibitive effect of miRNA on mRNA.
Figure 6Result of qPCR confirmation of miRNA microarray data subset.
Selected miRNA expression profile was validated in liver, spleen and lung between M. fortis and mice with qPCR, respectively. Expression rates between various samples are showed by fold change. The data presents the mean and standard error of the mean derived from triplicate experiments.